Flagship explainer

How Celldex Therapeutics, Inc. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$1.5M · 100%Cost of revenue$200000 · 13%Gross profit$1.3M · 87%Operating income−$287M · −18600%Income before tax−$259M · −16748%Income tax$0 · 0%Net income−$259M · −16748%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$1.5M100%
Cost of revenue$20000013%
$1.3M87%
−$287M−18600%
Income before tax−$259M−16748%
Income tax$00%
−$259M−16748%
Source: · event Dec 31, 2025 · retrieved Oct 17, 2026 · annual-row source set
Embed this chart

View the full Celldex Therapeutics, Inc. analysis at Buy Like Buffett

CLDX income explainer — Buy Like Buffett · Buy Like Buffett